Teva to pay over $4 billion to communities in pending nationwide opioid settlement
WASHINGTON, July 26, 2022 /PRNewswire/ -- Today, the National Prescription Opiate Litigation Plaintiffs' Executive Committee confirmed that they, alongside the working group of States' Attorneys General, counsel for Native American Tribes and plaintiffs' lawyers representing the States and local communities, have reached an agreement in principle with pharmaceutical manufacturer Teva on the primary financial terms of a nationwide opioid settlement. This agreement follows years of litigation naming Teva as a defendant responsible for fueling the opioid epidemic in America.
- This agreement follows years of litigation naming Teva as a defendant responsible for fueling the opioid epidemic in America.
- Announced today by Teva, this settlement is contingent upon finalization of terms between the working group and Teva.
- This settlement news comes as multidistrict federal litigation and state litigation continues in courtrooms around the country against other companies in the opioid supply chain.
- Teva and Allergan were defendants in thattrial until July 12, 2022 when the parties reached a $58M settlement agreement.